(Q46041489)

18 December 2017

title

Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum (English)

1 reference

18 December 2017

1 reference

Krystyna Gołembiowska

series ordinal

1

object named as

Krystyna Gołembiowska

1 reference

18 December 2017

2

Anna Dziubina

1 reference

18 December 2017

author name string

Magdalena Kowalska

series ordinal

3

1 reference

18 December 2017

Katarzyna Kamińska

series ordinal

4

1 reference

18 December 2017

publication date

1 February 2009

1 reference

18 December 2017

published in

Neurotoxicity Research

1 reference

18 December 2017

volume

15

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

155-166

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s12640-009-9016-2

exact match

0 references

cites work

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

1 reference

12 December 2020

Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists

1 reference

12 December 2020

Comparison of different tests for evaluation of catalepsy in rats

1 reference

12 December 2020

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

1 reference

12 December 2020

Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats

1 reference

12 December 2020

KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse

1 reference

12 December 2020

Neurodegeneration and neuroprotection in Parkinson disease

1 reference

12 December 2020

Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro

1 reference

12 December 2020

Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

1 reference

12 December 2020

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

12 December 2020

Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

1 reference

12 December 2020

Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease

1 reference

12 December 2020

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism

1 reference

12 December 2020

Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway

1 reference

12 December 2020

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

1 reference

12 December 2020

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia

1 reference

12 December 2020

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

12 December 2020

Monoamine oxidase, dopamine and Parkinson's disease

1 reference

12 December 2020

Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice

1 reference

12 December 2020

The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.

1 reference

12 December 2020

CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.

1 reference

12 December 2020

Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases

1 reference

12 December 2020

Targeting adenosine A2A receptors in Parkinson's disease

1 reference

12 December 2020

Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.

1 reference

12 December 2020

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications

1 reference

12 December 2020

Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain

1 reference

12 December 2020

Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.

1 reference

12 December 2020

Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation.

1 reference

12 December 2020

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

1 reference

12 December 2020

Acute interactions between L-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in mice.

1 reference

12 December 2020

Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist

1 reference

12 December 2020

1 reference

12 December 2020

Neurotransmitter receptors on microglia.

1 reference

12 December 2020

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

1 reference

12 December 2020

Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists

1 reference

12 December 2020

Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission

1 reference

12 December 2020

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

1 reference

12 December 2020

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

12 December 2020

Modulation of glial cell functions by adenosine receptors.

1 reference

12 December 2020

Oxidative stress and neurodegeneration: where are we now?

1 reference

12 December 2020

SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats

1 reference

12 December 2020

Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum

1 reference

12 December 2020

Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study

1 reference

12 December 2020

Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress

1 reference

12 December 2020

Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia

1 reference

12 December 2020

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

1 reference

12 December 2020

Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine

1 reference

12 December 2020

Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease

1 reference

12 December 2020

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

12 December 2020

Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

1 reference

12 December 2020

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons

1 reference

12 December 2020

Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors

1 reference

12 December 2020

10.1007/S12640-009-9016-2

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017